Rydex Energy Services Fund Class H
RYVAX
NASDAQ
| Weiss Ratings | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Reward Grade | B- | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Company Info | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Rydex Funds | |||
| Manager/Tenure (Years) | Michael P. Byrum (27), Adrian Bachman (2), Brendan Cain (2), 2 others | |||
| Website | http://www.guggenheiminvestments.com | |||
| Fund Information | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Rydex Energy Services Fund Class H | |||
| Category | Equity Energy | |||
| Sub-Category | Energy Sector Equity | |||
| Prospectus Objective | Specialty - Natural Resources | |||
| Inception Date | Apr 02, 1998 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 2,500.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.00% | |||
| Dividend | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 4.92% | |||
| Asset Allocation | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 1.89% | |||
| Stock | 99.68% | |||
| U.S. Stock | 92.38% | |||
| Non-U.S. Stock | 7.30% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | -1.56% | |||
| Price History | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.75% | |||
| 30-Day Total Return | 0.18% | |||
| 60-Day Total Return | -5.60% | |||
| 90-Day Total Return | -11.22% | |||
| Year to Date Total Return | -21.55% | |||
| 1-Year Total Return | -28.95% | |||
| 2-Year Total Return | -15.97% | |||
| 3-Year Total Return | -26.63% | |||
| 5-Year Total Return | 53.69% | |||
| Price | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $159.35 | |||
| 1-Month Low NAV | $152.49 | |||
| 1-Month High NAV | $166.23 | |||
| 52-Week Low NAV | $141.15 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $246.95 | |||
| 52-Week High Price (Date) | Jul 31, 2024 | |||
| Beta / Standard Deviation | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.28 | |||
| Standard Deviation | 37.05 | |||
| Balance Sheet | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 4.35M | |||
| Operating Ratios | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.65% | |||
| Turnover Ratio | 296.00% | |||
| Performance | RYVAX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | -2.60% | |||
| Last Bear Market Total Return | -19.81% | |||